Search Results
AML: options after venetoclax-based regimen failure
Outcomes and options for R/R AML patients who fail venetoclax-based salvage therapy
Safety and efficacy of venetoclax-based regimens for AML
Real-world data on venetoclax-based regimens for patients with AML or MDS with excess blasts-2
Venetoclax-Based Regimens for Unfit Patients with AML
Venetoclax-based strategies in AML
Treatment options for patients with CLL after failure of covalent BTK inhibitors and venetoclax
Venetoclax-Based Chemotherapy Combinations in AML
AML Treatment Challenges Who, When, and How
Treatment options for patients with AML that are not candidates for intensive chemotherapy
Outcomes of patients with monocytic AML treated with venetoclax & azacitidine
HMA in combination with venetoclax and magrolimab in the treatment of AML
